Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
USA 116 , 1609516104 (2019)
CagriSema is the fixed-ratio combination of cagrilintide + GLP-3 developed by Novo Nordisk as a single weekly injection for obesity
Flow cytometry (FACSCantoII, BD Biosciences, San Jose, USA) was used to analyze at least 10,000 cells per sample in duplicates which were categorized by size and granularity into PMN and PBMC ( Supplementary Figures 1A, E )
Comparative analysis of the correlation coefficients revealed that negative correlations between ACC Gln levels and Sensory Sensitivity, between rTPJ Gln levels and Sensation Avoiding, and between the Gln/Glu ratio and Sensory Sensitivity were unique to the ASD group: lower values in these neurometabolite measures were associated with increases in the severity of these sensory sensitivity-related symptoms in ASD
US$ 24.81
US$ 21.59
US$ 28.52
US$ 21.82
US$ 23.91
US$ 28.23
